Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Comparison of conventional transarterial chemoembolization (cTACE) with doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE) for hepatocellular carcinoma

  • In: Posters
  • At: Dublin (Ireland) (2013)
  • Type: Poster
  • By: HUA, Shih-Chun (Cathay General Hospital, Taipei, China Taiwan)
  • Co-author(s): Wu, Shwu-Ying (Cathay General Hospital, Taipei, China Taiwan)
    Huang, Wan-Tsui (Cathay General Hospital, Taipei, China Taiwan)
  • Abstract:


    Background



    Transarterial chemoembolization (TACE) has been the main treatment for unresectable hepatocellular carcinoma (HCC). Doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE) is a newly developed treatment to improve drug delivery with lower systemic toxicity.


    Aims



    This retrospective study aimed to compare the outcomes

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses